Clark T W
Department of Diagnostic Imaging, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, NS.
Can Assoc Radiol J. 2000 Aug;51(4):254-9.
To describe an ancillary technique when a conventional femoral approach to superior vena cava (SVC) stent placement is not feasible because of buckling of balloon catheters or stent-deployment systems during device advancement.
Three patients in whom device advancement across the SVC lesion from a femoral or axillary approach was unsuccessful were managed by accessing the right jugular vein; SVC lesions were crossed from an antegrade direction, and the jugular guidewire was secured at the femoral access site to create a through-and-through guidewire.
Countertraction on the through-and-through guidewire during stent placement and dilation permitted unhindered advancement of stent delivery systems and catheters across the SVC. Technical and clinical success was achieved in each patient with relief of SVC syndrome within 24-72 hours. Survival ranged from 26 to 137 days.
A through-and-through guidewire technique is useful when stenting a highly stenotic or thrombosed SVC in patients with superior vena cava syndrome.
描述一种辅助技术,用于在经股静脉途径行上腔静脉(SVC)支架置入时,由于在推进器械过程中球囊导管或支架输送系统发生弯曲而导致常规方法不可行的情况。
3例经股静脉或腋静脉途径推进器械穿过SVC病变未成功的患者,通过经右颈静脉入路处理;从顺行方向穿过SVC病变,并将颈静脉导丝固定在股静脉入路部位以建立贯通导丝。
在支架置入和扩张过程中,对贯通导丝进行反向牵引可使支架输送系统和导管顺利通过SVC。每位患者均取得技术和临床成功,SVC综合征在24 - 72小时内得到缓解。生存期为26至137天。
对于患有上腔静脉综合征的患者,在对高度狭窄或血栓形成的SVC进行支架置入时,贯通导丝技术是有用的。